Heart Attack News and Research

RSS

Immune dysfunction mechanism discovered in stroke and heart attack patients

Every year, between 250,000 and 300,000 people in Germany suffer from a stroke or heart attack.

23 Apr 2024

Unsheltered people are losing Medicaid in redetermination mix-ups

On a cold February morning at the Flathead Warming Center, Tashya Evans waited for help with her Medicaid application as others at the shelter got ready for the day in this northwestern Montana city.

23 Apr 2024

The relationship between calcium consumption at various times of the day and cardiovascular disease

The quantity of calcium consumed at breakfast and dinner was associated with cardiovascular disease (CVD).

23 Apr 2024

Risks of antipsychotic use in dementia extend beyond previous alerts, study shows

Antipsychotic use in people with dementia is associated with higher risks of a wide range of serious health outcomes compared with non-use, according to a new study from a collaboration across the Universities of Manchester, Nottingham, Edinburgh and Dundee.

23 Apr 2024

Study shows atrial fibrillation more dangerous in younger population

Atrial fibrillation (Afib), a common type of arrhythmia that is on the rise in people under the age of 65, is more dangerous in this increasingly younger population than previously thought, according to a new study published today in Circulation Arrhythmia and Electrophysiology and authored by physician-scientists at the UPMC Heart and Vascular Institute.

22 Apr 2024

ESC Preventive Cardiology 2024: Delving into burning issues about heart disease and much more

The hottest science in the prevention of heart disease awaits at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC).

22 Apr 2024

Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseases

Cardiovascular diseases, including stroke and myocardial infarction, are the world's leading causes of mortality, accounting for over 18 million deaths a year.

18 Apr 2024

Study reveals long-term consequences of atrial fibrillation

The lifetime risk of atrial fibrillation (a heart condition that causes an irregular and often abnormally fast heart rate) has increased from one in four to one in three over the past two decades, finds a study from Denmark in The BMJ today.

17 Apr 2024

Antipsychotics for dementia associated with elevated risks of serious adverse outcomes

Antipsychotic use in people with dementia is associated with elevated risks of a wide range of serious adverse outcomes including stroke, blood clots, heart attack, heart failure, fracture, pneumonia, and acute kidney injury, compared with non-use, finds a study published by The BMJ today.

17 Apr 2024

Universities collaborate on $15 million project investigating inflammation's role in cardiac and brain diseases

Research teams from Northwestern University Chicago Campus, University of Michigan and University of Pittsburgh will lead a $15 million project dedicated to studying inflammation's role in cardiac and brain diseases.

17 Apr 2024

Bidirectional Mendelian randomization uncovers link between plasma metabolites and heart attack risk

Myocardial infarction, more commonly known as a heart attack, is a leading cause of death worldwide. Biomarkers called plasma metabolites may play a key role in the physiological pathways involved in myocardial infarctions.

17 Apr 2024

Lifetime risk of atrial fibrillation rises to nearly 31% in recent decade

The risk of both AF and its complications in a Danish national cohort, beginning from the age of 45 years.

17 Apr 2024

Is spousal cardiovascular disease associated with an increased risk for depression?

Whether the spouses of those affected are more likely to become depressed after such events.

16 Apr 2024

Heart transplant recipient's journey: From patient to advocate

Glen Kelley's journey as a heart transplant recipient came full circle today in Prague, as he addressed attendees of the Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), including members of his own care teams.

12 Apr 2024

Patient-centered cardiovascular care enhances outcomes

Adult cardiovascular care centered on the patient can improve individuals' experiences and their medical outcomes, according to a new American Heart Association Scientific Statement published today in Circulation.

12 Apr 2024

Beta-blockers show no benefit for heart attack patients with normal heart function

The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.

8 Apr 2024

Preventive PCI reduces cardiac event risks in patients with high-risk plaque

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous coronary intervention (PCI), a procedure to open blocked arteries, compared with those who took medications alone but did not undergo PCI, according to research presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Edetate disodium-based chelation ineffective for heart attack patients with diabetes

People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke out of the body, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Study shows reduced bleeding risk with ticagrelor monotherapy after percutaneous coronary intervention

People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin alongside the P2Y12 inhibitor ticagrelor one month after undergoing percutaneous coronary intervention (PCI) saw a significantly reduced risk of clinically meaningful bleeding with no increased risk of clotting-related adverse events at 12 months compared with patients who continued taking aspirin and ticagrelor for a full year, in a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or "bad" cholesterol, levels by more than half on average, compared with a placebo.

8 Apr 2024

Heart Attack News and Research

Immune dysfunction mechanism discovered in stroke and heart attack patients

Unsheltered people are losing Medicaid in redetermination mix-ups

The relationship between calcium consumption at various times of the day and cardiovascular disease

Risks of antipsychotic use in dementia extend beyond previous alerts, study shows

Study shows atrial fibrillation more dangerous in younger population

ESC Preventive Cardiology 2024: Delving into burning issues about heart disease and much more

Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseases

Study reveals long-term consequences of atrial fibrillation

Antipsychotics for dementia associated with elevated risks of serious adverse outcomes

Universities collaborate on $15 million project investigating inflammation's role in cardiac and brain diseases

Bidirectional Mendelian randomization uncovers link between plasma metabolites and heart attack risk

Lifetime risk of atrial fibrillation rises to nearly 31% in recent decade

Is spousal cardiovascular disease associated with an increased risk for depression?

Heart transplant recipient's journey: From patient to advocate

Patient-centered cardiovascular care enhances outcomes

Beta-blockers show no benefit for heart attack patients with normal heart function

Preventive PCI reduces cardiac event risks in patients with high-risk plaque

Edetate disodium-based chelation ineffective for heart attack patients with diabetes

Study shows reduced bleeding risk with ticagrelor monotherapy after percutaneous coronary intervention

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News